Prellis Biologics For Profit

Osiris Therapeutics, Inc. is a stem cell company, which focuses on developing and marketing products to treat medical conditions.
Technology: Organ Engineering
Industry: Regenerative medicine
Headquarters: United States
Investors Number: 8
Total Funding: $185M
Estimated Revenue: $10M to $50M
Last Funding Type: Post-IPO Equity

Visit Website
melanie@prellisbio.com
twitter.com/Prellisbio
Register and Claim Ownership